Sawyer & Company’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.07K Hold
24
﹤0.01% 194
2026
Q1
$1.24K Hold
24
﹤0.01% 190
2025
Q4
$2.21K Hold
24
﹤0.01% 195
2025
Q3
$3K Hold
24
﹤0.01% 169
2025
Q2
$1.07K Hold
24
﹤0.01% 194
2025
Q1
$4K Hold
24
﹤0.01% 166
2024
Q4
$4K Hold
24
﹤0.01% 166
2024
Q3
$5K Hold
24
﹤0.01% 172
2024
Q2
$3K Hold
24
﹤0.01% 164
2024
Q1
$5.16K Hold
24
﹤0.01% 162
2023
Q4
$5K Hold
24
﹤0.01% 168
2023
Q3
$5K Hold
24
﹤0.01% 175
2023
Q2
$8K Hold
24
﹤0.01% 154
2023
Q1
$6K Hold
24
﹤0.01% 162
2022
Q4
$6K Buy
+24
New +$5.12K ﹤0.01% 170

Other funds holding INSP

Sawyer & Company's INSP Position: Q2 2026 in Review

Sawyer & Company held its Inspire Medical Systems (INSP) position steady in Q2 2026 at 24 shares worth $1.07K. The position accounts for ﹤0.01% of the portfolio, ranked #194.

Sawyer & Company first reported a position in INSP in Q4 2022 and has held it in 15 quarters since. The position peaked at $8K in Q2 2023. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Sawyer & Company held 24 shares of Inspire Medical Systems worth $1.07K as of Q2 2026.
  • Sawyer & Company left its Inspire Medical Systems share count unchanged in Q2 2026.
  • Inspire Medical Systems made up ﹤0.01% of Sawyer & Company's portfolio in Q2 2026, its #194 holding.
  • Sawyer & Company first reported a position in Inspire Medical Systems in Q4 2022 and has held it in 15 quarters since.
  • Sawyer & Company's Inspire Medical Systems position peaked at $8K in Q2 2023.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Sawyer & Company's 13F filing for Q2 2026, filed 23 Jul 2026.